Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2
Kasi Pandima Devi, Mahmoud Reza Pourkarim, Marijn Thijssen, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 2, pp. 425-430
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Oral antiviral treatments for COVID-19: opportunities and challenges
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1255-1278
Open Access | Times Cited: 70
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 19
Repositioning of Furin inhibitors as potential drugs against SARS-CoV-2 through computational approaches
Asmae Saih, Soukayna Baammi, Hicham Charoute, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-15
Closed Access
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
The Legacy of COVID-19 in Breast Milk: The Association of Elevated Anti-Inflammatory and Antimicrobial Proteins with Vaccination or Infection
Felicia Trofin, Petru Cianga, Daniela Constantinescu, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 182-182
Open Access
The dual actions of host miRNA-16a in restricting bovine coronavirus (BCoV) replication through targeting the host cell Furin and enhancing the host immune response
Abid Ullah Shah, Maged Gomaa Hemida
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Identification and characterization of collagen XXIII alpha 1 as a novel risk factor for eczema herpeticum
S. K. Chopra, Lennart M. Roesner, Katinka Döhner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Development and Prospects of Furin Inhibitors for Therapeutic Applications
Alexandre V. Ivachtchenko, Alexander Khvat, Dmitrii O. Shkil
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9199-9199
Open Access | Times Cited: 2
In vitro inhibition of SARS-CoV-2 Infection by dry algae powders
Daniel Garcia-Ruiz, Erendira Villalobos-Sánchez, David Alam-Escamilla, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry
Adonis Sfera, Karina G. Thomas, Sarvin Sasannia, et al.
Reports — Medical Cases Images and Videos (2022) Vol. 5, Iss. 2, pp. 22-22
Open Access | Times Cited: 8
Proprotein convertases regulate trafficking and maturation of key proteins within the secretory pathway
Laura Cendron, Sylvia Rothenberger, Leonardo Cassari, et al.
Advances in protein chemistry and structural biology (2022), pp. 1-54
Closed Access | Times Cited: 8
Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects
D. P. Nagahawatta, N. M. Liyanage, Thilina U. Jayawardena, et al.
Marine Life Science & Technology (2024) Vol. 6, Iss. 2, pp. 280-297
Closed Access | Times Cited: 1
Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19
Prashant Kumar Tiwari, Mandeep Chouhan, Richa Mishra, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Evaluation of Potential Furin Protease Inhibitory Properties of Pioglitazone, Rosiglitazone, and Pirfenidone: An In Silico Docking and Molecular Dynamics Simulation Approach
Ahtziri Socorro Carranza-Aranda, Carlos Daniel Díaz-Palomera, Eduardo Lepe-Reynoso, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8665-8684
Open Access | Times Cited: 1
The dual actions of miRNA16a in restricting Bovine Coronavirus replication through downregulation of Furin and enhancing the host immune response
Abid Ullah Shah, Maged Gomaa Hemida
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
Mariya Farooq, Abdul Waheed Khan, Bilal Ahmad, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
The dual actions of the host miRNA-16a in restricting Bovine coronavirus (BCoV) replication through targeting host cell Furin and in enhancing the host immune response.
Abid Ullah Shah, Maged Gomaa Hemida
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identifying Long COVID Definitions, Predictors, and Risk Factors in the United States: A Scoping Review of Data Sources Utilizing Electronic Health Records
Rayanne A. Luke, George Shaw, Geetha Saarunya, et al.
Informatics (2024) Vol. 11, Iss. 2, pp. 41-41
Open Access
The Role of Furin and Its Therapeutic Potential in Cardiovascular Disease Risk
Hannah Fry, Mohsen Mazidi, Christiana Kartsonaki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9237-9237
Open Access
Bryophyllum pinnatum methanolic extract and flavonoid-rich fraction regulate antioxidant/neurotransmitter levels in MSG-induced rat neurotoxicity
Lola Adeola Adelakin, P.B. Fakunle, Dorcas Taiwo-Ola, et al.
World Journal of Advanced Research and Reviews (2024) Vol. 23, Iss. 2, pp. 2711-2724
Open Access
In Vitro Evaluation of Antipseudomonal Activity and Safety Profile of Peptidomimetic Furin Inhibitors
Sara Maluck, Rivka Bobrovsky, Miklós Poór, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2075-2075
Open Access
Impact of genetic variations of gene involved in regulation of metabolism, inflammation and coagulation on pathogenesis of cardiac injuries associated with COVID-19
HariOm Singh, Aishwarya Nair, Supriya D. Mahajan
Pathology - Research and Practice (2024) Vol. 263, pp. 155608-155608
Closed Access
Flavonoids as Auxiliary Means in the Therapy and Prevention of COVID-19: Part II. Potential Targets
Ya. F. Zverev, A. Ya. Rykunova
Applied Biochemistry and Microbiology (2024) Vol. 60, Iss. 9, pp. 1674-1693
Closed Access
Identifying Long COVID Definitions, Predictors, and Risk Factors using Electronic Health Records: A Scoping Review
Rayanne Anderson Luke, George Shaw, Geetha S. Clarke, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top